Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Identify who maintains Index Calculations and why governance matters for accuracy and transparency. Learn about the roles, processes, and oversight that keep index data trustworthy.
6,672 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Opendoor stock popped today amid optimism about profitability progress and better unit economics. This article breaks...
In this in-depth millionaire interview, we chat with a seasoned investor who turned savvy saving into a durable fortu...
Polestar faces a pivotal period as it refines profitability and expansion amid a crowded EV field. This report outlin...
This original analysis breaks down First Watch's Q4 2025 results, translating the earnings transcript into practical ...
HP beats on EPS and revenue in the latest quarter as AI PCs gain share, but rising memory costs cast a shadow on marg...
New to crypto? This expert guide lays out beginner's picks for crypto investments, plus practical steps to buy safely...
A practical, investor-focused guide to vericel (vcel) 2025 earnings. Learn how revenue, margins, and milestones could...
Paradigm is preparing a $1.5B fund to invest in AI, robotics, and frontier technologies while maintaining crypto inve...
A QuidelOrtho Corp director purchases 10,000 shares amid a CFO retirement, sparking investor interest. This article e...
As investors await plug power (plug) 2025 Q4 results, this guide breaks down what the earnings call transcript could ...
When high-growth stocks stumble after earnings, it sparks questions for investors. This article digs into why On Hold...